Nectar Lifescience Ltd

BSE :532649 NSE :NECLIFE Sector : Pharmac..
29.32
Change: 1.96(7.16%)
52 week Low
26.15
52 week High
56.50
Day low
27.25
Day high
30.09
Prev Close
27.36
Open
27.36
6M return
-9.20%
1Y return
-33.21%
MCap(Rs. in Cr.)
613.58
Total Volume
33,91,167
Face Value : 1
Listed Since 18 Jul 2005
PE Ratio

Is the price-earnings ratio for valuing a company that measures its current share price relative to its earnings per share.

P/E RATIO
0
EPS

The earnings per share ratio is a portion of company's net profit allocated for each outstanding share. It is calculated by deducting preferred stock divided from the net income of the company divided by the number of outstanding shares.

EPS
0
PRICE/BOOK

Price-to-book ratio is used to compared the company's current market price with its book value.

PRICE/BOOK
Deliverable

These are the acutal number of shares that are traded on delivery based, meaning transfered from one person to another during the day's trade.

DELIVERABLES
0
DIV YIELD.(%)

Dividend Yield measures the quantum of cash dividends paid to shareholders in a financial year relative to the market value of the per share.

DIV YIELD.(%)
0

Company Details

Check out the key parameters of the company to understand the financial health and stock performance

Key Level

Resistance 1
-
Resistance 2
-
Support 1
-
Support 2
-

Moving Average

20 Days
-
50 Days
-
100 Days
-
200 Days
-
Growth in 3 years

Sales


Sales Industry Avg


PAT


PAT Industry Avg


No data available
No data available


Relative to Sensex rtn in 3 year


Relative to Nifty rtn in 3 year


Relative to top 3 MF rtn in 3 year


2016 2014 2014
Sales 59.91 59.91 59.91
Gross Profit 60.14 60.14 60.14
Operating Profit 6.14 6.14 6.14
Sales 59.91 59.91 59.91
Gross Profit 60.14 60.14 60.14
Operating Profit 6.14 6.14 6.14

Peer Companies

A quick glance on how stocks from the same sector have performed along with some key parameters

Nectar Lifesci.
29.32
Change: 1.96 (7.16%)
1 Year return
-33.21%
Risk (Std Dev)
0.13%
PE Ratio
36.01316
MCap( in Cr.)
613.58
Emcure Pharma
996.05
Change: 996.05 (0.00%)
1 Year return
0.00%
Risk (Std Dev)
-
PE Ratio
30.79489
MCap( in Cr.)
18,669.46
Sai Life
670.40
Change: -0.90 (-0.13%)
1 Year return
-12.33%
Risk (Std Dev)
0.00%
PE Ratio
101.19155
MCap( in Cr.)
13,962.34
Blue Jet Health
788.25
Change: 36.35 (4.83%)
1 Year return
127.26%
Risk (Std Dev)
0.10%
PE Ratio
55.55
MCap( in Cr.)
13,042.87
Sanofi Consumer
4,739.85
Change: 35.90 (0.76%)
1 Year return
-3.34%
Risk (Std Dev)
0.03%
PE Ratio
NM
MCap( in Cr.)
10,833.49
View More

Return Calculator

This tools helps you project your potential return on investments for the given stock, for a specified amount over a per-defined period of time.

 

If I had made
investment of  
in
Months Ago
My investment would be worth 0 with a of 0%

News

Stay tuned to the latest developments and happenings in the company.

Nectar Lifescience consolidated net profit rises 399.36% in the December 2024 quarter

Net profit of Nectar Lifescience rose 399.36% to Rs 7.84 crore in the quarter ended December 2024 as against Rs 1.57 crore during the previous quarter....

01 Feb 2025 07:43

Nectar Lifescience announces board meeting date

Nectar Lifescience will hold a meeting of the Board of Directors of the Company on 31 January 2025.Powered by Capital Market - Live News<....

24 Jan 2025 16:30

Nectar Lifescience consolidated net profit rises 449.02% in the September 2024 quarter

Net profit of Nectar Lifescience rose 449.02% to Rs 5.60 crore in the quarter ended September 2024 as against Rs 1.02 crore during the previous quarte....

14 Nov 2024 15:13

Nectar Lifescience schedules board meeting

Nectar Lifescience will hold a meeting of the Board of Directors of the Company on 14 November 2024Powered by Capital Market - Live News<....

04 Nov 2024 16:03

Nectar Lifescience to conduct AGM

Nectar Lifescience announced that the Annual General Meeting (AGM) of the company will be held on 21 September 2024.Powered by Capital Ma....

20 Aug 2024 16:12

Nectar Lifescience consolidated net profit rises 63.19% in the June 2024 quarter

Net profit of Nectar Lifescience rose 63.19% to Rs 2.97 crore in the quarter ended June 2024 as against Rs 1.82 crore during the previous quarter ende....

14 Aug 2024 15:21

View More
Subscribe for our
newsletter
Open Account Now